Off-Label Use Final Rule: US FDA Declines To Focus Solely On Promotional Claims

 
• By Brenda Sandburg

In final rule describing the types of evidence the agency will consider in determining the ‘intended use’ of a product, FDA rejects industry requests to exclude ‘circumstances surrounding distribution’ and product design or composition.

Off label
FDA issues final rule for determining off-label use of medical products • Source: Alamy

More from Marketing & Advertising

More from Compliance